Resilience After Infant Substance Exposure (RISE) Program
![Close-up of a newborns foot with monitoring device wrapped around a not so big, big toe](/sites/default/files/styles/landscape_150_3x2_1100x733_1x/public/2024-05/Photo-NEO-Resilience-After-Infant-Substance-Exposure-RISE-Hero-2624x1720-v01.jpg?itok=XsRNG96L)
If your newborn was exposed to substances such as opioids before birth, you want to know their health is in the hands of a compassionate team with experience providing the specialized care they need. The Resilience after Infant Substance Exposure (RISE) Program at Children’s Hospital of Philadelphia (CHOP) brings together all the experts your baby needs. RISE is a clinical care track within the Neonatal Follow-up Program (NFP) at CHOP. Our team members collaborate to identify and address the specific needs of you and your baby. We will work with you and your family to ensure the best possible experience and outcome.
How we serve you
Your baby's RISE team is made up of specialists who are not only experts in providing specialized care for infants who have been exposed to substances such as opioids before birth, but who are also involved in prevention, early intervention and treatment efforts to improve outcomes for infants and families.
Conditions we treat
Resilience after Infant Substance Exposure (RISE) provides specialized care for infants who have been exposed to substances, such as opioids, before birth and those suffering from neonatal opioid withdrawal syndrome (NOWS).
![Nurse holding an intensive care baby](/sites/default/files/styles/landscape_150_3x2_160x107_1x/public/2024-05/Photo-NEO-Resilience-After-Infant-Substance-Exposure-RISE-Why-Choose-2624x1720-v01.jpg?itok=9VRKauWL)
Why choose RISE
The RISE Program brings together experts across neonatology, pediatrics and early childhood development. Together, we take a compassionate and coordinated approach to identify and address the specific needs of you and your baby.
![Baby in incubator receiving TLC from staff](/sites/default/files/styles/landscape_150_3x2_160x107_1x/public/2024-05/Photo-NEO-Resilience-After-Infant-Substance-Exposure-RISE-Meet-Your-Team-2624x1720-v01.jpg?itok=UOvnAY7n)
Meet your team
Here in the RISE Program, a core team that includes neonatologists, pediatricians, physical therapists and social workers coordinates care with a broad team of specialists in primary and specialty healthcare, as well as community-based services.
![Smiling CHOP patient holding shopping bag](/sites/default/files/styles/square_100_160x160_1x/public/2024-06/Photo-Foundation-Shop-for-Chop-Become-Partner-Hero-2624x1720-v01.jpg?h=b840d9cf&itok=b_4zmn0L)
Our research
We are working to improve prevention, early intervention and treatment efforts to improve outcomes for our patients and their families.
What is NOWS?
Babies who were exposed to opioids before they were born are at risk of having neonatal opioid withdrawal syndrome (NOWS). This can cause a range of symptoms, such as body shakes, excessive crying, fever, diarrhea, trouble sleeping, poor feeding and breathing problems. Our team will work with you to find the best ways to treat your baby. Some babies may need medicine to help with the symptoms, while others may be soothed in non-medical ways. We will work with you to figure out the right treatment for your baby.
Your donation changes lives
A gift of any size helps us make lifesaving breakthroughs for children everywhere.
![Mother and son smiling](/sites/default/files/styles/landscape_150_3x2_160x107_1x/public/2024-03/Photo-Default-Donate-Mother-Hugging-Son-Patient-Ares-2624x1720-v01.jpg?h=26a2db72&itok=HWeHsHEa)